Stephen M Graham

Cumulative, additive benefits of memantine-donepezil combination over component monotherapies in moderate to severe Alzheimer’s dementia: a pooled area under the curve analysis

José Luis Molinuevo, Alireza Atri, John Edwards, 2015, Alzheimer's Research & Therapy.

Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial.

Pierre N Tariot, P. Tariot, M. Farlow, 2004, JAMA.

Memantine treatment in mild to moderate Alzheimer disease: a 24-week randomized, controlled trial.

Steven G Potkin, Nunzio Pomara, Brian R Ott, 2006, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

Behavioral effects of memantine in Alzheimer disease patients receiving donepezil treatment

Pierre N Tariot, P. Tariot, J. Cummings, 2006, Neurology.